668P Clinical factors that are prognostic for survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223

Authors :: A. Zlotta
Robert J. Hamilton
Srikala S. Sridhar
Padraig Warde
Husam Alqaisi
Charles Catton
Nazanin Fallah-Rad
Adrian G. Sacher
Aaron R. Hansen
Neil Fleshner
Di Maria Jiang
Esmail Mutahar Al-Ezzi
Marco A. J. Iafolla
Source :: Annals of Oncology. 31:S537-S538
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Radium-223
Oncology
medicine.medical_specialty
Prostate cancer
business.industry
Internal medicine
medicine
Hematology
Castration resistant
business
medicine.disease
medicine.drug

Full Text Access

Tools